Patients were diagnosed as follows: nine patients affected by PTPS deficiency (and identified PTS variants), two patients affected by Pterin‐four alpha‐carbinolamine dehydratase deficiency (and identified PCBD1 variants) and one patient affected by DHPR deficiency (and identified QDPR variants). This evidence concerns the gene PTS and dihydropteridine reductase deficiency.